Know Cancer

or
forgot password


N/A
18 Years
N/A
Open (Enrolling)
Both
Sarcopenia

Thank you

Trial Information


Inclusion Criteria:



- Men or women 18 years old or more,

- Able to understand the protocol and to give their written consent,

- Health insurance.

Specific inclusion criteria:

- Group A: volunteers 18 to 30 yrs; without any pathology,

- Group B: volunteers ≥ 70 yrs; without any pathology,

- Group C: Performance status (ECOG) < 4; patients included in CAPADOGE study
presenting curative cares for cancer by chemotherapy and/ or surgery and/or
hormonotherapy and/or radiotherapy.

Exclusion Criteria:

- Intense activity in 7 preceding days,

- Functional dependency,

- under a legal protection.

Specific non-inclusion criteria:

- Groups A & B: serious chronic disease,

- Group C: Palliative care.

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Viscoelasticity of the contracted Tibialis anterior muscle

Outcome Description:

Describe and compare the distribution curves of viscoelasticity of the contracted Tibialis anterior muscle, measured by the ARFI shear wave velocity, between each group.

Outcome Time Frame:

Day 1 (group A, B and C) and month 6 (group C only)

Safety Issue:

No

Principal Investigator

Nora FRULIO, Dr

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital, Bordeaux, France

Authority:

France: Ministry of Health

Study ID:

CHUBX 2011/29

NCT ID:

NCT01484821

Start Date:

November 2011

Completion Date:

May 2014

Related Keywords:

  • Sarcopenia
  • Sarcopenia
  • ARFI
  • DEXA
  • Cancer
  • Sarcopenia

Name

Location